top of page

Videnskabelige studier om mRNA

ANCA glomerulonephritis after the Moderna COVID-19 vaccination

ANCA

ANCA-Associated Vasculitis after Moderna COVID-19 Vaccination

ANCA

ANCA-associated vasculitis after Pfizer-BioNTech COVID-19 vaccination, two case reports

ANCA

ANCA-Associated Vasculitis Following Pfizer-BioNTech COVID-19 Vaccine

ANCA

ANCA-Associated Vasculitis following the First Dose of Pfizer-BioNTech COVID-19 Vaccine

ANCA

Anti-glomerular Basement Membrane Disease Concomitant with MPO-ANCA Positivity Concurrent with High Serum Levels of Interleukin-26 Following Coronavirus Disease 2019 Vaccination

ANCA

Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Renal Vasculitis Following COVID-19 Vaccination, A Case Report and Literature Review

ANCA

Antineutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis Following the Pfizer-BioNTech COVID-19 Vaccine

ANCA

Case Report, ANCA-Associated Vasculitis Presenting With Rhabdomyolysis and Pauci-Immune Crescentic Glomerulonephritis After Pfizer-BioNTech COVID-19 mRNA Vaccination

ANCA

Case Report, Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis With Acute Renal Failure and Pulmonary Hemorrhage May Occur After COVID-19 Vaccination

ANCA

Concurrent Antiglomerular Basement Membrane Nephritis and Antineutrophil Cytoplasmic Autoantibody-Mediated Glomerulonephritis After Second Dose of SARS-CoV-2 mRNA Vaccination

ANCA

De novo and relapsing necrotizing vasculitis after COVID-19 vaccination

ANCA

De-novo Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Following the mRNA-1273 Moderna Vaccine for COVID-19

ANCA

Dual-Positive MPO- and PR3-ANCA-Associated Vasculitis Following SARS-CoV-2 mRNA Booster Vaccination,l A Case Report and Systematic Review

ANCA

Granulomatosis with polyangiitis after Pfizer vaccination, a case report

ANCA

MPO-ANCA-associated vasculitis after the Pfizer BioNTech SARS-CoV-2 vaccination

ANCA

New-onset severe eosinophilic granulomatosis with polyangiitis following the third dose of mRNA COVID-19 vaccine A case report

ANCA

Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis after COVID-19 Vaccination

ANCA

Severe Rhabdomyolysis Complicated With Acute Kidney Injury Required Renal Replacement Therapy After Pfizer COVID-19 Vaccine

ANCA

Two adolescent cases of acute tubulointerstitial nephritis after second dose of COVID-19 mRNA vaccine

ANCA
bottom of page